Kerstin Papenfuss, PhD MBA

Kerstin Papenfuss is a Director at Panthura Ltd, a pharmaceutical company incorporated on April 24, 2024, in London, England.1 She holds a PhD and an MBA, and has over 12 years of experience in the biotechnology field.8

Professional Background

Dr. Papenfuss serves as a Director at Panthura, where she is listed as "Director, Pharmaceuticals".15 Her role at Panthura began on April 24, 2024, coinciding with the company's incorporation date.6

Prior to her position at Panthura, Dr. Papenfuss held various roles in the pharmaceutical and biotechnology sectors:

• Associate Director of Pharmaceuticals at Deep Science Ventures2
• Director at Hermogen Bio Ltd (appointed on August 23, 2024)5
• Director at Plurify Ltd5

Education and Research

Kerstin Papenfuss started her PhD at the German Cancer Research Centre and later continued her thesis at Imperial College London.3 This background in cancer research likely contributes to her expertise in the pharmaceutical industry.

Achievements and Notable Work

Dr. Papenfuss has been involved in significant initiatives in the field of genetic therapies:

1. She played a key role in a collaboration between the Cystic Fibrosis Foundation and Deep Science Ventures, aimed at developing genetic therapies for cystic fibrosis.2

2. On July 23, 2024, Dr. Papenfuss proudly announced the formation of Panthura, noting that it is their "pharma sector's first all-female founding team" with co-founders Alice Preston and Duygu Yilmaz.4

Personal

Kerstin Papenfuss is German and lives in England.1 She was born in May 1982.1

Dr. Papenfuss's work reflects her fascination with "the molecular mechanisms that create life and how we get sick when things go wrong"7, indicating a deep passion for her field of work in pharmaceuticals and biotechnology.